In addition, reduction of inflammatory factors, reduction of angiotensin II, and improvement of blood sugar and blood pressure by GLP-1RAs have been suggested as mechanisms of kidney protection effect
(Source: PMC12026077) Cardiovascular Benefits (TRIUMPH-4): Systolic blood pressure dropped by 14.0 mmHg at the 12mg dose
Acknowledgements The authors thank our lab members for their cooperation throughout this study
[16] [19] Subsequent analysis of SUSTAIN-6 data revealed that the increased risk was concentrated among patients who entered the trial with pre-existing diabetic retinopathy and experienced rapid improvements in glycemic control
Though the insurance coverage of GLP-1s remains spotty, Novo and Eli Lilly (makers of tirzepatide, the other major GLP-1 on the market) have steadily lowered the out-of-pocket cost of their drugs, particularly this year
The science is still sorting out exactly how much is weight-driven versus direct